Survey on cannabis use in Parkinson's disease: Subjective improvement of motor symptoms

  title={Survey on cannabis use in Parkinson's disease: Subjective improvement of motor symptoms},
  author={K. Venderov{\'a} and E. Rů{\vz}i{\vc}ka and V. Voř{\'i}{\vs}ek and P. Vi{\vs}ňovsk{\'y}},
  journal={Movement Disorders},
  • K. Venderová, E. Růžička, +1 author P. Višňovský
  • Published 2004
  • Medicine
  • Movement Disorders
  • An anonymous questionnaire sent to all patients attending the Prague Movement Disorder Centre revealed that 25% of 339 respondents had taken cannabis and 45.9% of these described some form of benefit. © 2004 Movement Disorder Society 
    115 Citations

    Topics from this paper

    Paper Mentions

    Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
    • 2
    Medical Cannabis in Parkinson Disease: Real-Life Patients' Experience
    • 29
    • Highly Influenced
    • PDF
    Cannabis use in people with Parkinson's disease and Multiple Sclerosis: A web-based investigation.
    • 33
    • PDF
    Cannabis in Parkinson's Disease: The Patients' View.
    Cannabinoids in the Treatment of Parkinson’s Disease
    • 2
    • PDF
    Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy
    • 11
    • PDF


    Marijuana for parkinsonian tremor.
    • 66
    • PDF
    Adjuncts to dopamine replacement: A pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease
    • J. Brotchie
    • Medicine
    • Movement disorders : official journal of the Movement Disorder Society
    • 1998
    • 116
    Cannabis in Movement Disorders
    • 82
    Blepharospasm with bilateral basal ganglia infarction.
    • 56
    Reflex blepharospasm associated with bilateral basal ganglia lesion
    • 31
    Decreased [18F]Spiperone Binding in Putamen in Idiopathic Focal Dystonia
    • 205
    • PDF
    Stuttering and gait disturbance after supplementary motor area seizure
    • 22
    Stimulation of cannabinoid receptors reduces levodopa‐induced dyskinesia in the MPTP‐lesioned nonhuman primate model of Parkinson's disease
    • 155